Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Boston Scientific Corporation before investing.

In this article, we go over a few key elements for understanding Boston Scientific Corporation’s stock price such as:

• Boston Scientific Corporation’s current stock price and volume
• Why Boston Scientific Corporation’s stock price changed recently
• Upgrades and downgrades for BSX from analysts
• BSX’s stock price momentum as measured by its relative strength

About Boston Scientific Corporation (BSX)

Before we jump into Boston Scientific Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Want to learn more about Boston Scientific Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Boston Scientific Corporation.

Boston Scientific Corporation’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Boston Scientific Corporation’s stock price was $46.730.

Boston Scientific Corporation is up 1.59% from its previous closing price of $46.000.

During the last market session, Boston Scientific Corporation’s stock traded between $44.430 and $46.800. Currently, there are approximately 1,484.90 million shares outstanding for Boston Scientific Corporation.

Boston Scientific Corporation’s price-earnings (P/E) ratio is currently at 19.6, which is low compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Boston Scientific Corporation Stock Price History

Boston Scientific Corporation’s (BSX) price is currently up 9.49% so far this month.

During the month of July, Boston Scientific Corporation’s stock price has reached a high of $47.160 and a low of $42.200.

Over the last year, Boston Scientific Corporation has hit prices as high as $109.500 and as low as $42.200. Year to date, Boston Scientific Corporation’s stock is down 50.99%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Boston Scientific Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Boston Scientific Corporation’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Boston Scientific Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Boston Scientific Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Boston Scientific Corporation’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Boston Scientific Corporation (BSX) by visiting AAII Stock Evaluator.

Relative Price Strength of Boston Scientific Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Boston Scientific Corporation has a weighted four-quarter relative price strength of -20.40%, which translates to a Momentum Score of 12 and is considered to be Very Weak.

Want to learn more about how Boston Scientific Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Boston Scientific Corporation Stock Price: Bottom Line

As of July 31, 2026, Boston Scientific Corporation’s stock price is $46.730, which is up 1.59% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Boston Scientific Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.